HopeStage
Back to all studies
CompletedNCT02233868

Brain Inflammation and Thinking in Alcohol Use Disorder

About this titleRead the official source — NCT02233868
Medication studyAges 30–75United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 30 years to 75 years.

What did participation involve?

The protocol includes: Having magnetic resonance imaging (MRI) scans.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 19, 2015
Recruitment status
Completed
Enrollment listed in the registry
74
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 30 Years to 75 Years
Official registry ID
NCT02233868
Official title
Show the full official title

Brain Inflammation and Function in Alcoholism

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Did this study involve medication?

Yes. The study involved medication, including neuroinflammation.

Who was this study for?

Listed age limits: 30 years to 75 years.

Want to explore more studies?

Explore studies